These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24846933)

  • 41. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.
    Lim W; Dentali F; Eikelboom JW; Crowther MA
    Ann Intern Med; 2006 May; 144(9):673-84. PubMed ID: 16670137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of a Standardized Perioperative Management Protocol in the Adult Hematology Anticoagulation Management Service.
    Lum DJ; Ross PA; Bishop MA; Caetano ML; Malpani R; Streiff MB
    Ann Pharmacother; 2017 Dec; 51(12):1077-1083. PubMed ID: 28677422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery.
    Douketis JD; Woods K; Foster GA; Crowther MA
    Thromb Haemost; 2005 Sep; 94(3):528-31. PubMed ID: 16268467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
    Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
    J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-molecular-weight heparin prophylaxis 24 to 36 hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism.
    Strom RG; Frempong-Boadu AK
    Spine (Phila Pa 1976); 2013 Nov; 38(23):E1498-502. PubMed ID: 23873245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of educational intervention on management of periprocedural anticoagulation.
    Awker AL; Bell MA; McGraw M; Klein MA
    Am J Health Syst Pharm; 2017 Dec; 74(23 Supplement 4):S95-S101. PubMed ID: 29167146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin.
    Harenberg J; Huisman MV; Tolle AR; Breddin HK; Kirchmaier CM
    Semin Thromb Hemost; 2001 Oct; 27(5):513-8. PubMed ID: 11668421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients.
    Attaya H; Wysokinski WE; Bower T; Litin S; Daniels PR; Slusser J; Heit JA; McBane RD
    J Thromb Thrombolysis; 2013 Jan; 35(1):100-6. PubMed ID: 22843195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-molecular-weight heparin in pregnancy: peripartum bleeding complications.
    Kominiarek MA; Angelopoulos SM; Shapiro NL; Studee L; Nutescu EA; Hibbard JU
    J Perinatol; 2007 Jun; 27(6):329-34. PubMed ID: 17443203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy and safety of low-molecular-weight heparin use for cancer treatment: a meta-analysis.
    Che DH; Cao JY; Shang LH; Man YC; Yu Y
    Eur J Intern Med; 2013 Jul; 24(5):433-9. PubMed ID: 23385011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
    Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
    J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty.
    Haighton M; Kempen DH; Wolterbeek N; Marting LN; van Dijk M; Veen RM
    J Orthop Surg Res; 2015 Sep; 10():145. PubMed ID: 26384316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and Efficacy of Bridging With Low-Molecular-Weight Heparin During Temporary Interruptions of Warfarin: A Register-Based Cohort Study.
    Sjögren V; Grzymala-Lubanski B; Renlund H; Svensson PJ; Själander A
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):961-966. PubMed ID: 28468510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Venous thromboembolism in lymphoma: how effectively are we treating patients?
    Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Daw HA
    Am J Clin Oncol; 2009 Oct; 32(5):521-3. PubMed ID: 19546801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of clinical decision support on adherence to thrombosis prophylaxis guidelines in medical patients; a single center experience.
    Eijgenraam P; Meertens N; van den Ham R; Ten Cate H; Ten Cate-Hoek AJ
    Thromb Res; 2015 Mar; 135(3):464-71. PubMed ID: 25538031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bridging of oral anticoagulation therapy for invasive procedures.
    Spyropoulos AC
    Curr Hematol Rep; 2005 Sep; 4(5):405-13. PubMed ID: 16131443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery.
    Bucci C; Geerts WH; Sinclair A; Fremes SE
    Am J Cardiol; 2011 Feb; 107(4):591-4. PubMed ID: 21184996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.